Literature DB >> 34295695

Erratum to pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy-case report.

.   

Abstract

[This corrects the article DOI: 10.21037/tlcr-20-1095.]. 2021 Translational Lung Cancer Research. All rights reserved.

Entities:  

Year:  2021        PMID： 34295695      PMCID： PMC8264349          DOI： 10.21037/tlcr-2021-3

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


In the February 2021 issue of Translational Lung Cancer Research (TLCR), the case report “Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy-case report” (1) was published with one error. The author Sanziana R. I. Schiopu had a third affiliation which should be added as below. 3. First Department of Internal Medicine, “luliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania Click here to view the updated version of the article.
  1 in total

1.  Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy-case report.

Authors:  Sanziana R I Schiopu; Lukas Käsmann; Ulf Schönermarck; Michael Fischereder; Ulrich Grabmaier; Farkhad Manapov; Josefine Rauch; Martin Orban
Journal:  Transl Lung Cancer Res       Date:  2021-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.